β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes

Diabetes

Volumn 52, Issue 1, 2003, Pages 102-110

  Butler, Alexandra E ^a   Janson, Juliette ^b   Bonner Weir, Susan ^c   Ritzel, Robert ^a   Rizza, Robert A ^d   Butler, Peter C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JOSLIN DIABETES CENTER   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPSY; BODY MASS; CELL COUNT; CELL DIVISION; CELL VOLUME; CONTROLLED STUDY; DIABETIC OBESITY; DIET RESTRICTION; EXOCRINE CELL; FEMALE; GLUCOSE INTAKE; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMYLOID; APOPTOSIS; CELL DEATH; CELL DIVISION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC DUCTS;

EID: 0037219411     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.1.102     Document Type: Article

References (54)

1. Kudva YC, Butler PC: Insulin secretion in type-2 diabetes mellitus. In Clinical Research in Diabetes and Obesity. Volume 2: Diabetes and Obesity. Draznin B, Rizza R, Eds. Totowa, NJ, Humana Press, 1997, p. 119-136
2. DeFronzo RA: Lilly Lecture 1987: The triumvirate: Cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
3. Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Int Med 159:1450-1456, 1999
4. Center for Disease Control and Prevention: Trends in the prevalence and incidence of self reported diabetes mellitus: United States, 1980-1994. MMWR 46:1014-1018, 1997
5. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995
6. Polonsky KS: Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord 24 (Suppl. 2):S29-S31, 2000
7. Flier SN, Kulkarni RN, Kahn CR: Evidence for a circulating islet growth factor in insulin resistant states. Proc Natl Acad Sci U S A 98:7475-7480, 2001
8. Ogilvie RF: The islands of Langerhans in 19 cases of obesity. J Pathol 37:473-481, 1933
9. Kloppel G, Mattias L, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110-125, 1985
10. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas: Estimation with a simple mathematical model. Diabetes 44:249-256, 1995
11. Bonner-Weir S: Islet growth and development in the adult. J Mol Endocrinol 24:297-302, 2000
12. Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: A long recognized but under appreciated pathological feature of type 2 diabetes. Diabetes 48:241-253, 1999
13. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84:8628-8632, 1987
14. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus. Nature 368:756-760, 1994
15. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H: Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A 92:1989-1993, 1995
16. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediatesized toxic amyloid particles. Diabetes 48:491-498, 1999
17. Gepts W: Contribution a l'etude morphologique des ilots de Langerhans au cours du diabete. Ann Soc Roy Sci Med Nat 10:1, 1957
18. Maclean N, Ogilvie R: Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4:367-376, 1955
19. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH: Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31:694-700, 1982
20. Saito K, Yaginuma N, Takahashi T: Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129:273-283, 1979
21. Rahier J, Goebbels RM, Henquin JC: Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371, 1983
22. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC: Islet amyloid, increased alpha cells, reduced beta cells and exocrine fibrosis; quantative changes in pancreas in type-2 diabetes. Diabetes Res 9:151-160, 1988
23. Guiot Y, Sempoux C, Moulin P, Rahier J: No decrease of the β-cell mass in type 2 diabetic patients. Diabetes 50 (Suppl. 1):S188, 2001
24. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96, 2002
25. O'Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC: Islet amyloid polypeptide in human insulinomas: Evidence for intracellular amyloidogenesis. Diabetes 43:329-336, 1994
26. Clarke MR, Baker EE, Weyant RJ, Hill L, Carty SE: Proliferative activity in pancreatic endocrine tumors: Association with function, metastases, and survival. Endocr Pathol 8:181-187, 1997
27. Fonseca V, Berger LA, Beckett AG, Dandona P: Size of pancreas in diabetes mellitus: A study based on ultrasound. Br Med J (Clin Res Ed) 291:1240-1241, 1985
28. Bonner-Weir S, Trent DF, Weir GC: Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544-1554, 1983
29. McCulloch DK, Koerker DJ, Kahn SE, Bonner-Weir S, Palmer JP: Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozotocin-administered baboons. Diabetes 40:673-679, 1991
30. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefebvre P, Butler PC: Decrease in β-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial heptic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001-2012, 2001
31. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP: Effects of hemipanreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898-930, 1990
32. Seaquist ER, Robertson RP: Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 89:1761-1766, 1992
33. Robertson RP, Lanz KJ, Sutherland DER, Seaquist ER: Relationship between diabetes and obesity. 9-18 Years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73:736-741, 2002
34. Butler AE, Janson J, Ritzel R, Sultana C, Soeller WC, Butler PC: Accelerated apoptosis overcomes increased replication to cause β-cell loss in diabetes in mice transgenic for h-IAPP (Abstract). Diabetes 51 (Suppl. 2):A7, 2002
35. Tyrberg B, Ustinov J, Otonkoski T, Andersson A: Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: Effects of the ob gene and compensatory growth of the implanted organ. Diabetes 50:301-307, 2001
36. Tse EO, Gregoire FM, Reusens B, Remacle C, Hoet JJ, Johnson PR, Stern JS: Changes of islet size and islet size distribution resulting from protein-malnutrition in lean (Fa/Fa) and obese (fa/fa) Zucker rats. Obes Res 5:563-571, 1997
37. Swenne I: The role of glucose in the vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic β-cells. Diabetes 31:754-760, 1982
38. Bonner-Weir S, Deery D, Leahy JL, Weir GC: Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53, 1989
39. Zhu M, Noma Y, Mizuno A, Sano T, Shima K: Poor capacity for proliferation of pancreatic β-cells in Otsuka-Long-Evans-Tokushima fatty rat, a model of spontaneous NIDDM. Diabetes 45:941-946, 1996
40. Swenne I, Andersson A: Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 25:269-272, 1983
41. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE: A second pathway for regeneration of adult exocrine and endocrine pancreas, a possible recapitulation of embryonic development., Diabetes 42:1715-1720, 1993
42. Bouwens L, Pipeleers DG: Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633, 1998
43. Boyd GL, Robinson WL: Evidence of regeneration of pancreas in an insulin treated case of diabetes. Am J Path 1:135-147, 1925
44. Westermark P, Wilander E: The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417-421, 1978
45. Howard CF: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301-306, 1986
46. Howard CF, Van Bueren A: Changes in islet cell composition during development of diabetes in Macaca nigra. Diabetes 35:165-171, 1986
47. De Koning EJP, Bodkin NL, Hansen BC, Clark A: Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in β-cell population. Diabetologia 36:378-384, 1993
48. O'Brien TD, Hayden DW, Johnson KH, Fletcher TF: Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. J Comp Pathol 96:357-369, 1986
49. Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide; pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036-5040, 1990
50. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
51. Soeller WC, Janson J, Emeigh Hart S, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-assocaited diabetes in obese Avy/a mice expressing human islet amyloid polypeptide. Diabetes 47:743-750, 1998
52. Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E: β-cell death and mass in syngeneicary transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66-72, 2002
53. Bretherton-Watt D, Ghatei MA, Bloom SR, Jamal H, Ferrier FJM, Girgis SI, Legon S: Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetelogia 32:881-883, 1989
54. Mulder H, Ahrén B, Stridsberg M, Sundler F: Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment. Diabetelogia 38:395-402, 1995